Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 May 17;107(6):e2651-e2652.
doi: 10.1210/clinem/dgac111.

Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS"

Affiliations
Comment

Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS"

Athanasios D Anastasilakis et al. J Clin Endocrinol Metab. .
No abstract available

Keywords: bisphosphonates; bone metastases; denosumab; osteonecrosis of the jaw; osteoporosis.

PubMed Disclaimer

Comment on

References

    1. Taguchi A. Letter to the Editor from Taguchi: “Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS.” J Clin Endocrinol Metab. Published online February 25, 2022. doi:10.1210/clinem/dgac109 - DOI - PubMed
    1. Anastasilakis AD, Pepe J, Napoli N, et al. . Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS. J Clin Endocrinol Metab. Published online December 18, 2021. doi:10.1210/clinem/dgab888 - DOI - PMC - PubMed
    1. Campos-Staffico AM, Freitas WM, Carvalho LSF, Coelho-Filho OR, Nadruz W Jr., Oliveira RBAC; Brasilia Study on Healthy Aging and Brasilia Heart Study. Lower bone mass is associated with subclinical atherosclerosis, endothelial dysfunction and carotid thickness in the very elderly. Atherosclerosis. 2020;292:70-74. - PubMed
    1. Lampropoulos CE, Papaioannou I, D’Cruz DP. Osteoporosis--a risk factor for cardiovascular disease? Nat Rev Rheumatol. 2012;8(10):587-598. - PubMed
    1. Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Yavropoulou MP, Makras P. Postmenopausal osteoporosis coexisting with other metabolic diseases: treatment considerations. Maturitas. 2021;147:19-25. - PubMed

MeSH terms

Substances